Speaker: Professor David Lynn, BA MSc PhD
Director, Computational & Systems Biology Program & EMBL Australia Group Leader, Systems Immunology Laboratory, SAHMRI / Scientific Director, SA Genomics Centre / Professor, College of Medicine & Public Health, Flinders University
Title: A systems immunology study to assess the impact of early-life antibiotic exposure on infant vaccine immune responses
Chair: Associate Professor Branka Grubor-Bauk, Viral Immunology Group
Zoom ID is 836 0891 8784 Password 070925 or click here for direct link
Speaker biography: Prof. David Lynn is a Group Leader in Systems Immunology and Program Director in the SAHMRI Precision Medicine Theme; Scientific Director of SA Genomics Centre; and Professor at Flinders University College of Medicine and Public Health. His research team apply systems immunology approaches to investigate how microbes (pathogenic and commensal) modulate the immune system in a range of contexts from infection (including COVID-19) to infant immunisation and cancer immunotherapy. He also has a strong interest in vaccine non-specific effects and trained immunity. His research spans from computational modelling and bioinformatics software development to mechanistic studies in preclinical mouse models (including gnotobiotic). He also leads a number of clinical studies including 3 NHMRC-funded systems vaccinology studies. He is also the PI in South Australia for the Gates Foundation-funded BRACE RCT, which is investigating whether BCG provides non-specific protection against COVID-19 in ~7,000 participants worldwide. Prof. Lynn’s research is currently supported by the NHMRC, MRFF, ARC, The Hospital Research Foundation, The Flinders Foundation and others.
